Webinar: How Biosimilar Rebates Shape Payer Policies, Provider Behavior

Video

A panel of experts discusses the ways in which payers restrict prescribing choices for physicians and what that means for the future of biosimilar utilization.

On July 20, 2020, MJH Life Sciences™ hosted the webinar "How Biosimilar Rebates Shape Payer Policies, Provider Behavior." Jeff Prescott, PharmD, senior vice president of Clinical Communications for MJH Life Sciences™ served as moderator. The panelists were Kathy Oubre, MS, chief operating officer of the Pontchartrain Cancer Center in Louisiana; Timothy Chiu, PharmD, BCPS, pharmacist evidence analyst and strategist for Kaiser Permanente; and Ali McBride, PharmD, MS, BCOP, FASHP, FAzPA, clinical coordinator of Hematology/Oncology for The University of Arizona Cancer Center in Tucson.

Related Videos
Fran Gregory, PharmD, MBA
Julie Reed, MS
Julie Reed, executive director of the Biosimilars Forum
 Fran Gregory, PharmD, vice president of emerging therapies, Cardinal Health.
Ryan Haumschild, PharmD, MS, MBA
Fran Gregory, PharmD, vice president of emerging therapies, Cardinal Health
Fran Gregory, PharmD, vice president of emerging therapies, Cardinal Health
Fran Gregory, PharmD, vice president of emerging therapies at Cardinal Health
andre harvin
Here are the top 5 biosimilar articles for the week of May 1, 2023.
Related Content
© 2023 MJH Life Sciences

All rights reserved.